Skip to main content
OpenTrials
Completed

NCT Number: NCT01005498

Comparison Between Low Carbohydrate Diet and Traditionally Recommended Diabetic Diet in the Treatment of Diabetes Mellitus Type 2.

The purpose of the clinical trial is to investigate whether low carbohydrate diet is better than the traditional diabetic diet in the treatment of patients with diabetes mellitus type 2, for blood sugar and body weight.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Vårdcentralen Lyckorna

Motala, Östergötland County, S-59185, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetes mellitus type 2

Exclusion criteria

  • Severe psychiatric disease or difficulties in understanding Swedish language.

Treatment and study plan

Low carbohydrate - high fat diet

Dietary Supplement

The diet has an energy content of 1600 kcal or 1800, with 50% from fat, 20% from carbohydrates and 30% from proteins.

High carbohydrate - low fat diet

Dietary Supplement

The diet has an energy content of 1600 or 1800 kcal, with 30% from fat, 55-60% from carbohydrates and 10-15% from proteins.

Primary outcomes

  1. Laboratory findings and body composition

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Vårdcentralen Lyckorna

Other

Registry information

Acronym: VÄSTKOST

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Nov 2, 2009
Registry last updated
Dec 6, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.